• Company plans to use proceeds from direct offering for business development, drug repurposing and discovery and expansion of its laboratory facilities
• POAI portfolio spans four different subsidiaries, including list of assets rivaling best operators in the space
• Predictive Oncology is strong standout in precision medicine

Predictive Oncology (NASDAQ: POAI) has closed on its registered direct offering (https://ibn.fm/9buhx).The offering, which totaled $21.34 million, will be a boon for the knowledge-driven company as it continues its focus on applying artificial intelligence (“AI”) to personalized medicine and drug discovery. Operating in the AI space, the company is looking at almost vast potential as it focuses efforts on personalized medicine and drug discovery. The POAI portfolio is impressive, spanning four different subsidiaries — Helomics, TumorGenesis, Soluble Biotech and Skyline Medical — and including a list of assets that rivals the best operators in the space (https://ibn.fm/knRZc). Leveraging the unparalleled expertise and rich resources it has assembled, POAI has established one of the largest databases available of clinically validated historical and outcome data from patient tumors, an in-house Clinical Laboratory Improvement Amendments (“CLIA”)-certified lab, and a novel approach to growing tumors in the lab that mimics the tumor in the patient’s own body. In addition, the company offers several innovative platforms, including a “smart” patient-derived tumor profiling platform; an in-house bioinformatics AI platform; and a comprehensive in silico platform, known as CORE and developed by top researchers from Carnegie Mellon University, that iteratively optimizes predictive models using a guided selection of experiments. Through its commitment to resources and innovative thinking, POAI has also gained a reputation for its expertise in specializing in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, a key piece of being able to move forward in personalize medicine, specifically in the cancer space. POAI has also become a recognized provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes, as well as endotoxin detection and removal. Finally, POAI has developed an FDA-approved fluid collection and disposal system. This strong portfolio makes POAI a strong standout in precision medicine, where precisely targeting drugs based on the genomic profile of the patient’s tumor, has become the aspiration for cancer therapy. “However, the reality is that while we can find many mutations in the patient’s tumor, most are not actionable with current drugs,” the company observes. “So, the race has begun to generate more data to understand which mutations are associated with what drug, in order to target therapy, a process that can take five to seven years of clinical evaluation to gather outcome data.” That’s where POAI enters the picture, “leveraging [its] unique, historical database of the drug responses of over 150,000 patient tumors to build data-driven predictive models of tumor drug response. These models will provide actionable insights critical to both new drug development and individualizing patient treatment. “Predictive Oncology prospectively may have a competitive advantage,” the company concludes. “The company already has a substantial historical database of tumors and related data, plus the ability to obtain the associated outcome data. While others must wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine. Predictive Oncology presently has the clinical information, including tumor drug response data and an in-house bioinformatics AI platform.” POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of more than 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow. For more information, visit the company’s website at www.Predictive-Oncology.com. NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

• Tryp Therapeutics will be participating in the second global Psych Investor Summit: Research and Development
• The virtual presentation is scheduled for July 7 from 11:50 a.m. to 12:50 p.m. EDT
• It will focus on the psychedelics industry, showcasing the latest research and development within the sector
• Mr. Greg McKee, Chairman and CEO of Tryp Therapeutics, will share information on the company, along with its drug development pipeline

In an official statement dated June 24, 2021, Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) confirmed that it would participate in the Psych Investor Summit: Research and Development. The virtual event, scheduled on Wednesday, July 7, 2021, from 11:50 a.m. to 12:50 p.m. EDT, will focus on the psychedelics industry, mainly showcasing the latest research and development within the sector (https://ibn.fm/cihuB). The event is also intended to expand businesses currently looking for capital, mainly by directly delivering the industry’s most promising opportunities to funds and investors. The July 7 event marks the second global psychedelics industry investment event that solely focuses on research and development. As has been the case with the previous events, this one is meant to showcase the latest clinical evidence for this promising sector. It will feature a concise half-day program, with provisions for interactions with industry leaders, global psychedelics investors and rising entrepreneurs (https://ibn.fm/QN5e7). Tryp Therapeutics is a pharmaceutical enterprise committed to developing bioscience solutions for conditions with unmet needs (https://ibn.fm/VFGjr). Its current flagship program involves developing a synthetic psychedelic drug candidate specifically designed to treat particular pain and eating disorder indications. Its trademarked Psilocybin-for-Neuropsychiatric Disorder (“PFN”) program is the basis for the company’s development of treatments for several diseases that lack effective treatment options (https://ibn.fm/Ol6Tb). At this Psych Investor Summit, Tryp Therapeutics, through its Chairman and Chief Executive Officer, Mr. Greg McKee, will share the strides that it has made so far. More specifically, Mr. McKee will delve into more detail on Tryp’s drug development pipeline and what it is doing to push the envelope regarding the use of psychedelics to treat specific types of pain and diseases (https://ibn.fm/zZu5V). Mr. McKee will also contribute to a panel discussion on the future of research and development and the development activities for psychedelic drug compounds. Other speakers presenting at the conference include Rick Doblin, the Founder and Executive Director of MAPS; Christian Angermayer, the Founder of atai Life Sciences; and Dr. Ben Sessa, the Chief Medical Officer at Awkn Life Sciences. For more information, visit the company’s website at www.TrypTherapeutics.com. Should you wish to attend the summit, you can register at www.Psych.Global/agenda/. NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

• Despite the worldwide economic difficulties imposed by the pandemic during the past year, new efforts at electric vehicle adoption are on the rise
• Ideanomics recently announced 100 percent acquisition of EV tractor manufacturer and distributor Solectrac Inc., which will grant it premium positioning in the agriculture industry’s growing interest in zero-emissions vehicles
• Ideanomics is also celebrating the launch of Technology Metals Market (“TM2”) trading using Nasdaq’s cloud-deployed matching technology for real-time pricing

Consumer interest in reducing the harmful effects of pollutants on the earth’s climate globally has led to a resurgence of electric-driven automotive technology in the world’s marketplace for private and commercial vehicles, nearly a century after the once-dominant electric vehicle industry became virtually extinct amid lower prices and mass production gains for gas-powered internal combustion engines (“ICEs”) (https://ibn.fm/1wJMo). While the United States has lagged somewhat in electric vehicle (“EV”) adoption compared to China and Northern Europe, and the COVID-19 pandemic has had a detrimental effect on new automotive sales this past year, the overall number of EV registrations in the United States still rose 36 percent during the first four months of 2021, according to an Automotive News report, and on a YOY basis for that period EV registrations rose 95 percent from 2020 (https://ibn.fm/im2Jd). New York-based company Ideanomics (NASDAQ: IDEX) is among a new wave of organizations injecting an estimated $16.3 billion overall into the EV start-up market this year — 28 per cent more than last year, according to market research company CB Insights (https://ibn.fm/QmWgH). Ideanomics’ announcement June 14 that it boosted its stake in California-based zero-emission electric tractors manufacturer and distributor Solectrac Inc. to 100 percent ownership (https://ibn.fm/ccJQb) not only highlighted applications of EV technology in the agricultural industry, but showcased Ideanomics’ drive to sustain next generation solutions for the world’s energy consumption and living standard equity difficulties. Solectrac has limited competition in the electric tractor market in North America, granting it a significant head start within the industry, the announcement states. Its premium electric tractor lineup is fully scalable and market-ready to generate revenue in the United States with proven demand. The announcement follows on the heels of Ideanomics’ acquisition of US Hybrid, a manufacturer of electric powertrain parts and fuel cell engines for heavy-duty municipal vehicles, commercial trucks, buses, and specialty cars (https://ibn.fm/ZoquR). “Ideanomics has emerged as a true powerhouse in the commercial EV sector with a synergistic ecosystem of technologies and solutions that covers the entire value chain of electrification,” US Hybrid CEO Gordon Abas Goodarzi stated in the news release announcing the deal. Ideanomics is also celebrating the launch of global technology metals marketplace trading platform Technology Metals Market (“TM2”), which is using Nasdaq’s cloud-deployed matching technology to provide investors with real-time pricing for trading a new asset class of high-value technology metals critical to global technology industries (https://ibn.fm/dH5BI). For more information, visit the company’s website at www.Ideanomics.com. NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

• SRAX’s Sequire SaaS platform provides tools to help public companies track shareholders, manage warrants, issue shareholder surveys
• SRAX recently featured in Wall Street Journal article highlighting volatility problems for public companies
• Sequire subscriber base doubled between Q3 and Q4 2020 to 183 public companies across 5 million+ active traders, investors

SRAX (NASDAQ: SRAX), a financial technology company, helps publicly traded companies unlock data and insights with Sequire, its SaaS investor analytics platform that features a unique set of tools that allows users to track investors, manage warrants, publish news and issue surveys. Since its creation in 2019, the platform has bloomed to over 5 million active retail investors across 180+ companies (https://ibn.fm/6cBli), nearly doubling its year-over-year bookings to $10 million in the first quarter of 2021 (https://ibn.fm/HHR8w). “Retail investors are more important now than ever, as they have been driving the market, and companies are starting to pay attention,” said SRAX founder and CEO Christopher Miglino. “Data on who investors are and what they invest in is a valuable asset to every public company. This data provides us deep insights into trends and movements of all types of investors.” Economic and political factors underpinned the severe market volatility experienced throughout much of 2020 and early 2021. Miglino was recently featured in a Wall Street Journal article highlighting the crippling volatility issues faced by public companies and how SRAX can help them address the problem (https://ibn.fm/4psZ9). “Our sales have increased significantly over the past two quarters,” Miglino stated in the article, confirming that the platform provides critical information about shareholder activity. As a company that went public in 2012, SRAX management intimately understands the challenges faced by public companies, and built the platform specifically to help managers unlock the power of critical market data. Features like the Situation Room produce real-time market information, including level two trading data, current share price, volume change, % change, and more. In addition, the warrant management feature manages warrant holders’ activity and keeps track of warrant expiration dates while calculating proceeds at different price scenarios in an interactive data-driven environment. Sequire doesn’t stop at providing insights – the platform allows users to take action through communication1 tools that engage new and existing investors through marketing campaigns across email, social media, and more. “Our team did an amazing job in delivering a number of cutting-edge technological improvements to the platform and they have laid the foundation for some amazing enhancements that we will bring to market throughout the rest of this year,” said Miglino. “I could not be more proud of the hard work and dedication that the team has demonstrated as our sales continue to skyrocket.” SRAX is committed to helping public companies unlock the power of data through Sequire, its premier investor intelligence and communication SaaS platform. As concerns about market volatility continue to mount, public companies are turning to Sequire to access tools that provide clarity, increase engagement, and build loyalty with shareholders. For more information, visit the company’s websites at www.SRAX.com and www.MySequire.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Before global pandemic, telehealth was more of novelty than necessity
• Virtual care resonating with patients; almost 88% want to continue using telehealth after COVID-19 has passed
• Earlier this year, ISWH launched TeleCare Home Health LLC, a wholly owned telehealth and home healthcare subsidiary

Even as COVID-19 appears to be subsiding in the United States, the impact of the pandemic will likely have long-lasting impact in many industries. An area of great interest to ISW Holdings (OTC: ISWH), a global brand management holdings company, is telehealth because the company has commercial operations in that space. A recent Healthcare Finance articles reported that almost 88% of Americans want to continue using telehealth for nonurgent consultations even after COVID-19 has passed (https://ibn.fm/98pHO). “Before the COVID-19 pandemic, telehealth was more of a novelty than a necessity,”     the article stated. “The concept of touching base with a doctor remotely was promising, but there were hurdles. Now, though, with many of those hurdles at least temporarily lifted — due to policy changes at the federal level — more consumers have received a taste of what telehealth is like. And most liked it, at least enough to want to keep using it after the pandemic has become a memory. “That was the main finding of a new Sykes survey that polled 2,000 Americans in March on how their opinions on virtual care have changed within the past year,” the article continued. “And it comes at a time when most Americans have now experienced telehealth in some form: In March 2020, fewer than 20% had experienced a telehealth appointment. By March of this year, more than 61% had undergone a telehealth visit.” The article goes on to note that numbers recorded over that same year suggest virtual care is resonating with patients. “A year ago, about 65% of Americans felt hesitant or doubtful about the quality of telehealth, and 56% did not believe it was possible to receive the same level of care as compared to in-person appointments,” the article observed. “Now, almost 88% want to continue using telehealth for nonurgent consultations after COVID-19 has passed, while almost 80% say it’s possible to receive quality care.” The continuation of telehealth as an option in the medical care could be a boon to patients and healthcare providers alike. The survey reported some of the reasons patients preferred virtual visits. “A significant number, 61%, experienced telehealth for the first time because their physician’s office moved their appointments to virtual visits,” the article stated. “Twenty-eight percent said it was a convenient option for immediate care, while about 24% proactively asked their physicians office to switch to virtual appointments. About 18% made the switch after reading more about telehealth, 17% were persuaded by people they know, and 12% became convinced to try it after learning more about it from broadcast news.” While telehealth was a popular — and common option during the pandemic, not everyone has had a telehealth experience. However, a vast majority of those who haven’t yet tried telehealth, more than 77%, say they’re more willing to do so, as compared to 59% a year ago. “Meanwhile about 40% feel that the quality is comparable to an in-person visit, a 9% jump from 2020,” the survey continued. “Further data details the extent to which Americans are warming to telehealth. Eighty-five percent say it has made it easier to get the care they need; 62% said they were afraid of going to the doctor, but those fears were eased during their telehealth visit; 51% say they’re able to see their doctor more often; 31% say their healthcare costs have decreased; and 31% feel their doctor comes across as more empathetic during virtual visits. Finally, “three-quarters said they believe telehealth will become the norm for nonurgent medical consultations after the pandemic, and about 65% said they’d prefer to have parts of their annual physical done remotely,” the survey noted. All those numbers point to good things for ISWH, as projections for the virtual care during 2020 looks to reach at least $29 billion in total healthcare services; the same forecast notes that up to $106 billion of current U.S. healthcare spend could be virtualized by 2023. “This highlights the high rates of adoption among both patients and physicians, and the impetus felt among providers to offer safe, secure and easy-to-use virtual services as demand for telehealth continues to grow.” ISWH has already established itself as a technology, home healthcare and wellness company. Earlier this year, the company officially announced its launch of TeleCare Home Health LLC, a wholly owned telehealth and home healthcare subsidiary (https://ibn.fm/a35kk). For more information, visit the company’s website at www.ISWHoldings.com. NOTE TO INVESTORS: The latest news and updates relating to ISWH are available in the company’s newsroom at http://ibn.fm/ISWH

• GTVH closes on acquisition of the Lodge Winery & Olive Oil Co. under the company’s Food & Wine Division, Napa Wine Brands Inc.
• Included in the acquisition is a wide range of brands and products.
• Company committed to broaden horizon of food and wine company by creating a platform different than anything seen in the northern hemisphere.

Golden Triangle Ventures (OTC: GTVH) is making a strong statement about its confidence in the $67-billion U.S. wine industry (https://ibn.fm/nvRRP) with its recent acquisition announcement. In May, the company acquired the Lodge Winery & Olive Oil Co. under the company’s Food & Wine Division, Napa Wine Brands Inc. (https://ibn.fm/dJZ1c). “Our marketing team is now ready to launch an in-depth program focused on driving our products into big box stores, smaller retail outlets, online platforms and many other avenues,” said Golden Triangle Ventures CEO Steffan Dalsgaard. “We have great relations with many people in the food and beverage industry, and we also intend to develop many brands and products within Napa Wine Brands that will supply some of our future endeavors across other divisions within Golden Triangle Ventures. We are working directly with Arron and his team to grow their bulk inventory and launch all of these products for the world to enjoy.” Napa Wine Brands was founded by CEO Arron Johnson, a longtime resident of the famed northern California Sonoma and Napa Valley wine country regions. Included in the newly announced acquisition is a wide range of brands and products under the Napa Wine Brands, Inc. umbrella, which now includes the Lodge Winery & Olive Oil Co. The Lodge Winery & Olive Oil Co. is an established wine brand that produces award-winning wines and locally grown and milled single-varietal extra virgin olive oils along with a variety of award-winning wine vinegars. Currently, the winery offers wines from Napa Valley and Sonoma County as well as surrounding regions. Napa Wine Brands is committed to manufacture and distribute specialty wines, foods and unique wine country gift items as well as explore an array of other potential markets in the gift, food and beverage industry. The company is committed to broaden the horizon of a traditional food and wine company by creating a platform different than anything currently seen in the northern hemisphere. “I’m beyond excited about this acquisition and what the future has in store for Napa Wine Brands and the many other upcoming brands and products I’ve developed that are associated with the Lodge Winery & Olive Oil Co.,” said Johnson. “We intend to develop this company into a premium destination winery in the number-one attraction of California, the wine country.” Golden Triangle Ventures is a multifaceted consulting company with many projects being developed that provide synergistic values in the health, entertainment and technology industries. The company aims to purchase, acquire and/or joint venture with established entities that management can help assist and develop into unique opportunities. Additionally, GTVH provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion and commitment to these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. For more information, visit the company’s website at www.GoldenTriangleInc.com. NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://ibn.fm/GTVH

• BAND Royalty has rolled out its first of four series of visionary NFT collectibles, granting them unique status by attaching them to potential revenue opportunities stemming from music artist royalties
• BAND’s stable of music royalty possibilities includes songs sung by artists such as Beyonce, Cher, Justin Timberlake, and Rihanna in its first series
• BAND’s art DeFi offering helps fans claim a personal financial stake in beloved music artists
• The remaining three series of NFT offerings, each with 3,000 “albums” of graduated levels of rarity, with roll out of over the next 18 months along with an NFT-supported token that provides fans further opportunities to share in music royalties
• The first series of NFTs launched with a private pre-sale that netted BAND more than $700,000 in Ethereum equivalence before transferring the remainder of the albums to the public market

The non-fungible token (“NFT”) market gained a revolutionary new player this year when BAND Royalty applied its experience in music industry investments to the digital art collectibles arena in order to create a new type of best-of-both-worlds product. “I’ve been buying and investing in (music royalties) for almost 20 years,” BAND co-founder Noble Drakoln said during a live-streamed raffle of the final number in BAND’s first series of NFT “albums” May 27 (https://ibn.fm/mKrDa). “As I’ve been in the NFT space helping other companies, I realized that there was an opportunity to merge both NFT art, which was getting really popular, … with a potential DeFi project that allowed people to share in music royalties. Because, why not? Most art and most NFTs have nothing behind them. It’s just what (investors) think other people think is going to be more valuable.” BAND Royalty’s first series of 3,000 NFTs, available for sale to the public May 15 following a private pre-sale that alone netted over $700,000 in Ethereum equivalence from the most-sought-after albums in the series, presents digital works of art in a forum typical of NFT collectibles and then offers opportunities for the buyers to stake the NFTs if they want to use them to obtain a pooled apportionment of select musicians’ royalties. The first series includes royalties from music catalog selections featuring artists such as Justin Timberlake, Jay-Z, Beyonce and Timbaland. “It’s a secret hidden world of investing. People don’t know they can buy performance royalties of major acts. … And that these rights are always floating out there for people to acquire them on various songs that these artists performed on,” Drakoln said during the album raffle, which highlighted BAND’s collaboration with crypto exchange LATOKEN. “We listen to all these people on the radio and we don’t know that there’s actually an income stream being developed.” BAND’s website illustrates the process for obtaining potential earnings from the NFTs, beginning with a purchase of lowest vinyl-level albums (the series includes a scaled roster of increasing rarity of albums from vinyl through varied gold and platinum levels to the most-limited diamond levels) for 1 ETH each using a Metamask or Trust wallet. That puts the buyer in BAND’s Music Mogle Club, and qualifies the buyer for staking opportunities in pools that may derive royalties either from published printing of the songs, mechanical reproductions of the songs or synchronization of the songs in outside media such as ads or movies. Then, every time a song earns royalties in the applicable pooled category, 50 percent of the revenue is divvied up among the people holding shares in the pool. “These are amazing ways to participate and to really give extra value to the beauty of the NFT art you collect,” Drakoln said, noting that BAND will also tokenize the NFTs once the first series is completed to allow more people to participate and have an opportunity to access the music royalties. The company plans to have a maximum of 12,000 BAND NFTs divided among four different series, with the remaining three series to be released over the next 18 months (https://ibn.fm/00j9v). BAND also expects to eventually launch its own music label with a cadre of artists. “We’re one of the most unique NFTs in the marketplace. No one’s ever seen this. We’re attached to world-class platinum performers,” Drakoin said. For more information, visit the company’s website at www.BANDRoyalty.com. NOTE TO INVESTORS: The latest news and updates relating to BAND Royalty are available in the company’s newsroom at https://ibn.fm/BAND

• SRAX’s Sequire SaaS platform provides tools to help public companies track shareholders, manage warrants, issue shareholder surveys
• SRAX recently featured in Wall Street Journal article highlighting volatility problems for public companies
• Sequire subscriber base doubled between Q3 and Q4 2020 to 183 public companies across 5 million+ active traders, investors

SRAX (NASDAQ: SRAX), a financial technology company, helps publicly traded companies unlock data and insights with Sequire, its SaaS investor analytics platform that features a unique set of tools that allows users to track investors, manage warrants, publish news and issue surveys. Since its creation in 2019, the platform has bloomed to over 5 million active retail investors across 180+ companies (https://ibn.fm/6cBli), nearly doubling its year-over-year bookings to $10 million in the first quarter of 2021 (https://ibn.fm/HHR8w). “Retail investors are more important now than ever, as they have been driving the market, and companies are starting to pay attention,” said SRAX founder and CEO Christopher Miglino. “Data on who investors are and what they invest in is a valuable asset to every public company. This data provides us deep insights into trends and movements of all types of investors.” Economic and political factors underpinned the severe market volatility experienced throughout much of 2020 and early 2021. Miglino was recently featured in a Wall Street Journal article highlighting the crippling volatility issues faced by public companies and how SRAX can help them address the problem (https://ibn.fm/4psZ9). “Our sales have increased significantly over the past two quarters,” Miglino stated in the article, confirming that the platform provides critical information about shareholder activity. As a company that went public in 2012, SRAX management intimately understands the challenges faced by public companies, and built the platform specifically to help managers unlock the power of critical market data. Features like the Situation Room produce real-time market information, including level two trading data, current share price, volume change, % change, and more. In addition, the warrant management feature manages warrant holders’ activity and keeps track of warrant expiration dates while calculating proceeds at different price scenarios in an interactive data-driven environment. Sequire doesn’t stop at providing insights – the platform allows users to take action through communication tools that engage new and existing investors through marketing campaigns across email, social media, and more. “Our team did an amazing job in delivering a number of cutting-edge technological improvements to the platform and they have laid the foundation for some amazing enhancements that we will bring to market throughout the rest of this year,” said Miglino. “I could not be more proud of the hard work and dedication that the team has demonstrated as our sales continue to skyrocket.” SRAX is committed to helping public companies unlock the power of data through Sequire, its premier investor intelligence and communication SaaS platform. As concerns about market volatility continue to mount, public companies are turning to Sequire to access tools that provide clarity, increase engagement, and build loyalty with shareholders. For more information, visit the company’s websites at www.SRAX.com and www.MySequire.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Friendable’s Fan Pass platform has provided revenue streams for artists that may not have existed due to the global pandemic
• Version 2.0 of the Fan Pass artist streaming platform to be released on July 24, 2021, which also marks the first anniversary of the platform
• Friendable has signed a Letter of Intent for the production of musical-artist NFTs and the creation of a “Fanpasscrypto” marketplace

The global music streaming market was valued at $24.4 billion in 2020 and is expected to grow by a CAGR of 17.8%, resulting in $76.9 billion in revenue by 2027 (https://ibn.fm/v0NFs). The increase is largely driven by the COVID-19 pandemic, with a growing number of users turning to streaming platforms in the absence of live events. Even with the lockdown restrictions from the COVID-19 pandemic loosening, many venues have not opened their doors to full capacity. Companies like Friendable (OTC: FDBL), and its immersive artist streaming platform Fan Pass, are helping the music industry overcome pandemic challenges by offering multiple revenue-generating opportunities for artists both online and in venues, in a new and exciting model to promote and enjoy music. Launched at the height of the pandemic, the Fan Pass live streaming platform was designed to help artists maintain and find new earning opportunities, as well as give fans access to the artists they love, and support the industry in general. The platform has since grown exponentially and has become a valuable tool for artists to continue sharing their work, generating fan engagement and revenue, even as venues are opening. To provide even more value to its artist members and fans, Friendable is launching a 2.0 version of the Fan Pass platform, with new features and benefits for users, while also running a comprehensive 120-day strategy designed to build value in the business of livestreaming and live event content. “These next several months are going to lead us to and eventually through our version 2 mobile and web app releases, which will include an entirely new suite of features, virtual currency options, automation and, ultimately, scale,” Friendable CEO Robert A. Rositano Jr. said (https://ibn.fm/08Rjh). “It is our intent to grow our base, build our revenues and begin monetizing across the board, which we believe to be very achievable based on the results we have seen since our launch and every month following. It’s time to unveil several new features to our artists, and we look forward to watching the artists’ revenues, along with the company’s steadily increase with this next version. Stay tuned!” The Fan Pass platform is a virtual stage where artists and fans unite for one-of-a-kind shows and interactions through mobile or desktop applications. Initially launched on July 24, 2020, Fan Pass didn’t start gaining momentum until the beginning of 2021, now doubling and tripling artist sign-ups. The 2.0 version of the application is coming out on July 24, 2021, exactly one year since the initial product was launched. Fans who want to subscribe to the live music streaming platform can do so online, with a monthly plan costing about what a music download would cost on another platform. Fans can also opt for a yearly plan – gaining access to a 20% discount on the plan overall. Additionally, users can sign up for the exclusive “All Access VIP” content, which includes:

• Live performances and online concerts
• Livestreaming studio sessions
• Backstage meetups – before, during, and after a set
• Behind-the-scenes footage of video and photoshoots
• Special interviews and one-on-one videos
• Streaming highlights from “a day in the life” of a fan’s favorite artist

Artists can sign up for the Fan Pass platform for free, gaining access to a dashboard of options that allow for uploading exclusive content right away. Each artist is eligible for various revenue streams through the engagement of fans and participation in live streaming events. For example, exclusive “ticket-only” performances gain artists 100% of the sales for their shows. Through Fan Pass, artists can also take advantage of the Pro Services, which offer artists merchandising, marketing, and other helpful tools (without the necessity of a record label). Recently, Friendable and Santo Blockchain Labs and Santo Mining Corp. (OTC: SANP) signed a Letter of Intent to further extend revenue opportunities to develop global entertainment and musical-artist driven non-fungible tokens (“NFTs”). NFTs are units of data stored on the blockchain, certifying that the asset is unique and not interchangeable. The agreement also calls for the creation of an exclusive “Fanpasscrypto” marketplace (https://ibn.fm/hhoZ6). The company also rewards top artists for engagement every month, running month-long contests with cash and tangible rewards. In the past, prizes have included cash, GoPros, merchandising packages, marketing packages, streaming gear, and more. The Fan Pass platform is poised to offer even more features and opportunities for artists and fans in the upcoming 2.0 release. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• Infobird is launching the Next Generation of SaaS in China to grab a massive share of the massive and growing cloud infrastructure market
• The company is leveraging the huge growth opportunity represented by the boom of cloud infrastructure triggered by the shift towards cloud computing by businesses
• Inforbird is one of the few SaaS companies that can serve SMEs with its no-code development platform

Infobird (NASDAQ: IFBD) is a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company, focused on developing AI-driven customer engagement solutions, especially for the finance segment. A premier provider of customer engagement software-as-a-service (“SaaS”) solutions in China, the company is leveraging automated and smart capabilities to maximize value for its clients. Infobird has a long-standing reputation for offering advanced cloud computing solutions to increase revenue, reduce costs, and enhance service quality and customer satisfaction. At present, Infobird is launching the next generation of SaaS in China to ride on the high growth wave in the cloud infrastructure sector. This mammoth growth can be predicted by China’s accelerating cloud migration attributed to the long-term digitalization trends of the country’s economy plus a surge in use of cloud and SaaS solutions by business enterprises. The emergence of the pandemic which led to remote work opportunities has also accelerated the increased acceptance of cloud business services (https://ibn.fm/UsDQW). Over 90% of companies in China are still small- to medium-sized enterprises (“SMEs”), which contribute roughly 60% to China’s GDP. SMEs have a lower revenue contribution although their customization needs are not very complex as compared to bigger enterprises. SaaS companies that can solve these complex issues and offer viable solutions will emerge victorious in grabbing a significant share of the market revenue. While SME‘s do not have the budget for significant hardware and software updates, they can switch to SaaS subscription for improved services and reduced costs. Inforbird is one of the few SaaS companies well-equipped to serve the SME’s by leveraging its no-code development platform. Moreover, China’s SaaS market is fragmented and the top 10 vendors make up only 35% of the total market share. This leaves an enormous potential in the SaaS market to be explored by an efficient newcomer. With its many years of operational experience in the country, Infobird has served many leading enterprises in various industries, such as China Guangfa Bank and multinational eCommerce giant Alibaba Group Holding Limited (NYSE: BABA). For more information, visit the company’s website at www.Infobird.com/en/index.html. NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD